Atlas Trials

Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Clinical trial NCT00650234 · COMPLETED

Trial details

NCT number
NCT00650234
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-02-01
Primary completion
2004-03-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.